Home
Conditions
Influenza, Human

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 84 recruiting studies

Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

NCT02594189

Conditions: Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2, Infections, Influenza, Human, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

NCT02949011

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Not specified

View Trial Details

Completed

Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults

NCT00868218

Conditions: Healthy, Infections, Influenza, +6 more
Locations: Haukeland Univeristy Hospital Bergen, Norway

View Trial Details

Completed

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

NCT00968539

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

NCT02233816

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Broward Research Group Hollywood, Florida, United States

Miami Research Associates Miami, Florida, United States

View Trial Details

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

NCT03460743

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Clinical Research Institute Saltillo Saltillo, Coahuila, Mexico

Centro de Investigacion Clinica del Pacifico Acapulco de Juárez, Guerrero, Mexico

AMIC Pachuca Pachuca, Hidalgo, Mexico

Instituto Jalisciencie de Metabolismo Guadalajara, Jalisco, Mexico

View Trial Details

Completed

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

NCT01114620

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Fukuoka, Japan

View Trial Details

Completed

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

NCT03455491

Conditions: Acute Respiratory Viral Infections, Infections, Influenza, +6 more
Locations: City Clinical Hospital №9 Izhevsk, Russia

Kuban State Medical University Krasnodar, Russia

City Clinical Hospital №1 n.a. Semashko Rostov-on-Don, Russia

Ryazan State Medical University n.a. Pavlov Ryazan, Russia

View Trial Details

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population

NCT02236052

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: MUHC-Vaccine Study Centre Pierrefonds, Quebec, Canada

Centre de recherche-CHU de Québec Québec, Canada

inVentiv Health Clinique Québec, Canada

View Trial Details

Completed

Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children

NCT02649192

Conditions: Healthy Participants, Infections, Influenza, Human, +5 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Influenza, Human

Influenza, Human trial results

Related conditions